ObjectivesVarious genomic alterations and genomic signatures, including ERBB2 amplification, mutations in PIK3CA, AKT1, and ESR1, and tumor mutational burden (TMB), have become important biomarkers fo
Table S4. List of genes differently expressed between normal and tumor METABRIC samples and with concordant results with TCGA breast cancer analyses. (XLSX 39 kb)
This is a compilation of significant (p<10-8) GWAS hits - compiled from data available through Neale Laboratory (http://www.nealelab.is/uk-biobank) - We provide this list for ease of use as the lar
